0 Comments
0 Shares
353 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Oral Cancer Treatment Market Intelligence Report: Industry Trends, Investment Opportunities and Forecast"According to the latest report published by Data Bridge Market Research, the Oral Cancer Treatment Market Data Bridge Market Research analyses that the oral cancer treatment market, USD 1,805.8 million in 2022, would rise to USD 2,729.72 million by 2030 and is expected to undergo a CAGR of 5.30% during the forecast period 2023 to 2030. The idea of this Oral Cancer Treatment...0 Comments 0 Shares 354 Views 0 Reviews
-
Alpha Emitters Market Driven by Rising Cancer Treatment DemandThe alpha emitters market is experiencing rapid growth as targeted radiopharmaceutical therapies gain increasing recognition in oncology. Alpha-emitting isotopes offer highly precise cancer treatment by delivering potent radiation directly to tumor cells while minimizing damage to surrounding healthy tissues. Growing investments in nuclear medicine, expanding clinical research, and increasing...0 Comments 0 Shares 141 Views 0 Reviews
-
Anthracycline-Based Oncology Drug Class Market Advances with Continued Role in Chemotherapy Regimens and Expanding Cancer Treatment ApplicationsAccording to the latest report published by Data Bridge Market Research, the Anthracycline-Based Oncology Drug Class Market The global anthracycline-based oncology drug class market size was valued at USD 5.40 billion in 2025 and is expected to reach USD 7.33 billion by 2033, at a CAGR of3.90% during the forecast period A talented team works strictly with their potential...0 Comments 0 Shares 594 Views 0 Reviews
-
Basal Cell Skin Cancer Treatment Market Competitive Analysis: Key Players and Strategic CollaborationsThe global Basal Cell Skin Cancer Treatment Market is witnessing substantial growth due to the increasing prevalence of skin cancer cases worldwide, rising awareness regarding early diagnosis, and continuous advancements in targeted therapies and minimally invasive treatment procedures. Basal cell carcinoma (BCC), recognized as the most common form of skin cancer, has created a strong demand...0 Comments 0 Shares 490 Views 0 Reviews
-
Blood Cancer Treatment Market Anticipated to Reach USD 18.4 Billion by 2036 on Back of Rising Blood Cancer IncidenceThe Blood Cancer Treatment Market is expected to witness robust growth as the global healthcare industry continues to advance precision oncology and personalized cancer therapies. According to Future Market Insights (FMI), the market is projected to grow from USD 7.7 billion in 2026 to USD 18.4 billion by 2036, registering a 9.1% CAGR during the forecast period. Rising incidence of...0 Comments 0 Shares 164 Views 0 Reviews
-
Cachexia Treatment Market Expands with Advancements in Supportive Care Therapies and Growing Focus on Cancer-Associated Weight Loss ManagementAccording to the latest report published by Data Bridge Market Research, the Cachexia Treatment Market The global cachexia treatment market size was valued at USD 2.31 billion in 2025 and is expected to reach USD 3.49 billion by 2033, at a CAGR of 5.30 % during the forecast period The comprehensive Cachexia Treatment Market report offers a thorough overview of product specification,...0 Comments 0 Shares 408 Views 0 Reviews
-
Cancer Treatment Drugs Market to Reach USD 359.83 Billion by 2032 Driven by Immunotherapy and Precision Oncology AdvancementsAccording to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...0 Comments 0 Shares 553 Views 0 Reviews
-
Global endometrial cancer treatment market growth outlook with 4.5% CAGR (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comments 0 Shares 358 Views 0 Reviews
-
Global endometrial cancer treatment market growth outlook with 4.5% CAGR (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comments 0 Shares 384 Views 0 Reviews
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comments 0 Shares 2K Views 0 Reviews1
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comments 0 Shares 2K Views 0 Reviews1
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comments 0 Shares 9K Views 0 Reviews
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Comments 0 Shares 5K Views 0 Reviews
-
Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...0 Comments 0 Shares 3K Views 0 Reviews
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Comments 0 Shares 2K Views 0 Reviews
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Comments 0 Shares 2K Views 0 Reviews
-
Bone Pain Treatment Market Key Trends Shaping Industry ExpansionBone pain remains one of the most common and debilitating symptoms associated with orthopedic disorders, cancer metastasis, osteoporosis, arthritis, and musculoskeletal injuries. Increasing prevalence of chronic bone-related conditions and the growing aging population are significantly driving demand for advanced pain management solutions worldwide. Healthcare providers are increasingly...0 Comments 0 Shares 628 Views 0 Reviews
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Comments 0 Shares 5K Views 0 Reviews1
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Comments 0 Shares 2K Views 0 Reviews
More Results